Jefferies Group LLC Axonics, Inc. Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $163,174 - $266,119	-4,131 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$43.74 - $62.76 $180,689 - $259,261	4,131 New	4,131 $258,000
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $180,689 - $259,261	4,131 New	4,131 $259,000
Q3 2020 Nov 13, 2020	SELL	$35.33 - $51.04 $43,455 - $62,779	-1,230 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $17,526 - $30,469	765 Added 164.52%	1,230 $43,000
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $7,644 - $17,544	465 New	465 $12,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.